Xiao Liang, Qingxian Tu, Jie Zhang, Min Xu, Zhenglong Wang
{"title":"肝素结合蛋白与急性冠状动脉综合征患者院内心力衰竭风险的关系","authors":"Xiao Liang, Qingxian Tu, Jie Zhang, Min Xu, Zhenglong Wang","doi":"10.62347/LQLD9274","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the relationship between heparin-binding protein (HBP) levels and the risk of involving heart failure occurring during hospitalization in patients with acute coronary syndrome (ACS).</p><p><strong>Methods: </strong>This single-center retrospective study included 274 patients with ACS hospitalized at the Third Affiliated Hospital of Zunyi Medical University between June and December 2023. The primary outcome was the occurrence of in-hospital heart failure (HF). Multivariable logistic regression and restricted cubic spline (RCS) models were used to assess the relationship between HBP and HF. Receiver operating characteristic (ROC) curves were used to evaluate the predictive value of HBP for HF events.</p><p><strong>Results: </strong>During hospitalization, 56 patients (20.4%) developed HF. Patients with HF patients had higher HBP levels (<i>p</i> < 0.01). HBP was significantly associated with in-hospital HF risk (Model 3 OR = 4.232, <i>P</i> < 0.001). ROC analysis showed that HBP had a predictive value for HF events (AUC = 0.696, sensitivity = 55.36, specificity = 76.61, <i>P</i> < 0.001). The RCS model indicated a nonlinear dose-response relationship between HBP levels and in-hospital HF (<i>P</i> for nonlinearity = 0.007).</p><p><strong>Conclusion: </strong>HBP levels are associated with an increased risk of in-hospital HF in patients with ACS and serve as a superior predictor compared to traditional parameters and inflammatory markers.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 6","pages":"4237-4246"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261142/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association of heparin-binding protein with risk of in-hospital heart failure in patients with acute coronary syndrome.\",\"authors\":\"Xiao Liang, Qingxian Tu, Jie Zhang, Min Xu, Zhenglong Wang\",\"doi\":\"10.62347/LQLD9274\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To investigate the relationship between heparin-binding protein (HBP) levels and the risk of involving heart failure occurring during hospitalization in patients with acute coronary syndrome (ACS).</p><p><strong>Methods: </strong>This single-center retrospective study included 274 patients with ACS hospitalized at the Third Affiliated Hospital of Zunyi Medical University between June and December 2023. The primary outcome was the occurrence of in-hospital heart failure (HF). Multivariable logistic regression and restricted cubic spline (RCS) models were used to assess the relationship between HBP and HF. Receiver operating characteristic (ROC) curves were used to evaluate the predictive value of HBP for HF events.</p><p><strong>Results: </strong>During hospitalization, 56 patients (20.4%) developed HF. Patients with HF patients had higher HBP levels (<i>p</i> < 0.01). HBP was significantly associated with in-hospital HF risk (Model 3 OR = 4.232, <i>P</i> < 0.001). ROC analysis showed that HBP had a predictive value for HF events (AUC = 0.696, sensitivity = 55.36, specificity = 76.61, <i>P</i> < 0.001). The RCS model indicated a nonlinear dose-response relationship between HBP levels and in-hospital HF (<i>P</i> for nonlinearity = 0.007).</p><p><strong>Conclusion: </strong>HBP levels are associated with an increased risk of in-hospital HF in patients with ACS and serve as a superior predictor compared to traditional parameters and inflammatory markers.</p>\",\"PeriodicalId\":7731,\"journal\":{\"name\":\"American journal of translational research\",\"volume\":\"17 6\",\"pages\":\"4237-4246\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-06-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261142/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of translational research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.62347/LQLD9274\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/LQLD9274","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨急性冠脉综合征(ACS)患者住院期间肝素结合蛋白(HBP)水平与发生累及性心力衰竭风险的关系。方法:本研究为单中心回顾性研究,纳入2023年6月至12月在遵义医科大学第三附属医院住院的274例ACS患者。主要终点是院内心力衰竭(HF)的发生。采用多变量logistic回归和限制性三次样条(RCS)模型评估HBP与HF之间的关系。采用受试者工作特征(ROC)曲线评价HBP对心衰事件的预测价值。结果:住院期间发生心衰56例(20.4%)。HF患者的HBP水平较高(p < 0.01)。HBP与院内HF风险显著相关(模型3 OR = 4.232, P < 0.001)。ROC分析显示HBP对HF事件具有预测价值(AUC = 0.696,敏感性= 55.36,特异性= 76.61,P < 0.001)。RCS模型显示HBP水平与院内HF呈非线性剂量-反应关系(非线性P = 0.007)。结论:与传统参数和炎症标志物相比,HBP水平与ACS患者院内HF风险增加相关,可作为更好的预测指标。
Association of heparin-binding protein with risk of in-hospital heart failure in patients with acute coronary syndrome.
Objectives: To investigate the relationship between heparin-binding protein (HBP) levels and the risk of involving heart failure occurring during hospitalization in patients with acute coronary syndrome (ACS).
Methods: This single-center retrospective study included 274 patients with ACS hospitalized at the Third Affiliated Hospital of Zunyi Medical University between June and December 2023. The primary outcome was the occurrence of in-hospital heart failure (HF). Multivariable logistic regression and restricted cubic spline (RCS) models were used to assess the relationship between HBP and HF. Receiver operating characteristic (ROC) curves were used to evaluate the predictive value of HBP for HF events.
Results: During hospitalization, 56 patients (20.4%) developed HF. Patients with HF patients had higher HBP levels (p < 0.01). HBP was significantly associated with in-hospital HF risk (Model 3 OR = 4.232, P < 0.001). ROC analysis showed that HBP had a predictive value for HF events (AUC = 0.696, sensitivity = 55.36, specificity = 76.61, P < 0.001). The RCS model indicated a nonlinear dose-response relationship between HBP levels and in-hospital HF (P for nonlinearity = 0.007).
Conclusion: HBP levels are associated with an increased risk of in-hospital HF in patients with ACS and serve as a superior predictor compared to traditional parameters and inflammatory markers.